Strategic Trial Design
The initial spark that sets off our clinical trial design process is a bright idea that comes to us from the strong mind of a Medical Oncologist. Then, thanks to MedSIR’s innovative set-up, these ideas are transformed into strategic clinical trials that contemplate patient benefit, scientific advance, and efficient drug development.
Today, over 200 ideas now populate our Intellectual Pipeline and involve some of the newest and most impactful drugs on the market -or currently in development- such as pertuzumab, olaparib, niraparib, T-DM1, palbociclib, neratinib, osimertinib, RAD-223, pembrolizumab, atezolizumab, and many more.
A few key factors help us to go from initial idea to the set-up of a successful clinical trial:
1. We understand current and future market trends, which enables us to design coherent and relevant trials not only thinking about today, but also, our patients of tomorrow.
2. Our quick and flexible approach allows us to work efficiently and adapt our trials to your CDPs, company policies and strategies, finding win-win situations for both parties.
3. Our expert team is at the forefront of its domain and strives to draw up the best strategies that are both clinically and scientifically relevant.
«We design our studies synergistically with our clients thanks to sharing a common goal: improving the lives of our patients and their families»